Jonathan S Cebon

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
 
Loading... 3 0 20 0 false

Publications

Results 121-140 of 150 (Search time: 0.026 seconds).

Publication YearTitleAuthor(s)
12119-Nov-2005A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.Gan, Hui K ; Mitchell, Paul L R ; Galettis, Peter; Davis, Ian D; Cebon, Jonathan S ; de Souza, Paul; Links, Matthew
1228-Jul-2005Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.Harris, Marion T; Berlangieri, Salvatore U ; Cebon, Jonathan S ; Davis, Ian D; Scott, Andrew M 
12322-Feb-2005Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J
1242005Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.Murphy, R; Green, S; Ritter, G; Cohen, L; Ryan, D; Woods, W; Rubira, M; Cebon, Jonathan S ; Davis, Ian D; Sjolander, A; Kypridis, A; Kalnins, Renate M; McNamara, M; Moloney, M B; Ackland, J; Cartwright, Glenn A; Rood, J; Dumsday, G; Healey, K; Maher, D; Maraskovsky, Eugene; Chen, Y T; Hoffman, E W; Old, Lloyd J; Scott, Andrew M 
12516-Nov-2004Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.Schnurr, Max; Chen, Qiyuan; Shin, Amanda; Chen, Weisan; Toy, Tracey; Jenderek, Corinna; Green, Simon; Miloradovic, Lena; Drane, Debbie; Davis, Ian D; Villadangos, Jose; Shortman, Ken; Maraskovsky, Eugene; Cebon, Jonathan S 
12614-Oct-2004Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway.Schnurr, Max; Toy, Tracey; Shin, Amanda; Wagner, Moritz; Cebon, Jonathan S ; Maraskovsky, Eugene
12723-Sep-2004The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.Shackleton, Mark; Davis, Ian D; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin; Chen, Qiyuan; Parente, Phillip; Jefford, Michael; Masterman, Kelly-Anne; Caron, Dania; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
1281-Aug-2004A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.Jackson, Heather M; Dimopoulos, Nektaria; Chen, Qiyuan; Luke, Tina; Yee Tai, Tsin; Maraskovsky, Eugene; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
12916-Jul-2004The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.Vaughan, Hilary A; St Clair, Fiona; Scanlan, Matthew J; Chen, Yao-Tsen; Maraskovsky, Eugene; Sizeland, Andrew; Old, Lloyd J; Cebon, Jonathan S 
13014-Jun-2004Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.Chen, Qiyuan; Jackson, Heather M; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
13115-Apr-2004NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors.Maraskovsky, Eugene; Sjölander, Sigrid; Drane, Debbie P; Schnurr, Max; Le, Thuy T T; Mateo, Luis; Luft, Thomas; Masterman, Kelly-Anne; Tai, Tsin-Yee; Chen, Qiyuan; Green, Simon; Sjölander, Anders; Pearse, Martin J; Lemonnier, Francois A; Chen, Weisan; Cebon, Jonathan S ; Suhrbier, Andreas
1321-Apr-2004A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer.Mitchell, Paul L R ; Basser, R L; Chipman, M; Grigg, Andrew P ; Mansfield, R; Cebon, Jonathan S ; Davis, Ian D; Appia, F; Green, M
1339-Oct-2003Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells.Schnurr, Max; Toy, Tracey; Shin, Amanda; Hartmann, Gunther; Rothenfusser, Simon; Soellner, Julia; Davis, Ian D; Cebon, Jonathan S ; Maraskovsky, Eugene
1348-May-2003Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli.Jefford, Michael; Schnurr, Max; Toy, Tracey; Masterman, Kelly-Anne; Shin, Amanda; Beecroft, Tina; Tai, Tsin Yee; Shortman, Ken; Shackleton, Mark; Davis, Ian D; Parente, Phil; Luft, Thomas; Chen, Weisan; Cebon, Jonathan S ; Maraskovsky, Eugene
13520-Mar-2003ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling.Schnurr, Max; Toy, Tracey; Stoitzner, Patrizia; Cameron, Paul; Shin, Amanda; Beecroft, Tina; Davis, Ian D; Cebon, Jonathan S ; Maraskovsky, Eugene
1361-Jan-2003Rational approaches to human cancer immunotherapy.Davis, Ian D; Jefford, Michael; Parente, Phillip; Cebon, Jonathan S 
13715-Aug-2002Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.Luft, Thomas; Jefford, Michael; Luetjens, Petra; Toy, Tracey; Hochrein, Hubertus; Masterman, Kelly-Anne; Maliszewski, Charlie; Shortman, Ken; Cebon, Jonathan S ; Maraskovsky, Eugene
1381-Apr-2002IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.Luft, Thomas; Luetjens, Petra; Hochrein, Hubertus; Toy, Tracey; Masterman, Kelly-Anne; Rizkalla, Mark; Maliszewski, Charlie; Shortman, Ken; Cebon, Jonathan S ; Maraskovsky, Eugene
13915-Jan-2002IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.Luft, Thomas; Jefford, Michael; Luetjens, Petra; Hochrein, Hubertus; Masterman, Kelly-Anne; Maliszewski, Charlie; Shortman, Ken; Cebon, Jonathan S ; Maraskovsky, Eugene
1401-Dec-2001Hepatocellular carcinoma and chemoembolization.Harris, M; Gibbs, P; Cebon, Jonathan S ; Jones, R ; Sewell, Richard B; Schelleman, Tony; Angus, Peter W